RenewalBio

Private

IsraelHealthcare & Life Scienceshttps://www.renewal.bio/

Last Round

Seed

Nov 11, 2025

Total Funding Raised

$400,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RenewalBio is a biotechnology company that develops a synthetic-embryo and stem-cell therapeutics platform intended to generate transplantable tissues and rejuvenated cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

stem cell therapyregenerative medicinesynthetic embryoscellular therapiesorgan regenerationiPSCsinduced pluripotent stem cellsembryo modelsautologous cell therapyStembroid platformtissue engineeringcell therapy platformhematopoietic stem cellsage-related diseasesinfertility treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RenewalBio Comparables

Compare RenewalBio with similar companies based on industry and business-model similarity.

RenewalBio comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

RenewalBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 11, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Vladik Krupalnik

CEO , Co-Founder And Board Member

Founding Team

RenewalBio Investors

Notable investors and investment history

RenewalBio investors
Investor	Rounds
LongGame Ventures	Seed
Calm Ventures	Seed
YZi Labs	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 16, 2026
Monthly visitors increased 281% MoM, reaching 666.
Dec 27, 2025
Grew 17% QoQ, from 18 to 21 employees.

View all signals

RenewalBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RenewalBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RenewalBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range20

Year Founded2022

Last FundingNov 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.